🍁 New & forthcoming in #BDCP this month:
🇺🇸 Case series on perioperative use of bypassing agent #eptacogbeta in #haemophilia A & major #surgery
🇬🇧 Qualitative study exploring #treatment disparities and #QoL impacts in non-severe haemophilia
🔗 https://loom.ly/uIXcNF8
#HemeSky #MedSky
🍁 New & forthcoming in #BDCP this month: 🇺🇸 Case series on perioperative use of bypassing agent #eptacogbeta in #haemophilia A & major #surgery 🇬🇧 Qualitative study exploring #treatment disparities and #QoL impacts in non-severe haemophilia 🔗 https://loom.ly/uIXcNF8 #HemeSky #MedSky
0 vue
Publié le 22/10/2026 07:01
🍁 New & forthcoming in #BDCP this month:
🇺🇸 Case series on perioperative use of bypassing agent #eptacogbeta in #haemophilia A & major #surgery
🇬🇧 Qualitative study exploring #treatment disparities and #QoL impacts in non-severe haemophilia
🔗 https://loom.ly/uIXcNF8
#HemeSky #MedSky
0 commentaire
?